UnitedHealth Group Inc (UNH) Holdings Cut by Palouse Capital Management Inc.

Palouse Capital Management Inc. reduced its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,772 shares of the healthcare conglomerate’s stock after selling 335 shares during the quarter. Palouse Capital Management Inc.’s holdings in UnitedHealth Group were worth $3,930,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in UNH. White Lighthouse Investment Management Inc. acquired a new stake in shares of UnitedHealth Group in the second quarter valued at $324,000. Wells Fargo & Company MN increased its stake in shares of UnitedHealth Group by 0.5% in the second quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock valued at $1,887,377,000 after buying an additional 39,480 shares in the last quarter. Granite Investment Advisors LLC increased its stake in shares of UnitedHealth Group by 1.4% in the second quarter. Granite Investment Advisors LLC now owns 34,225 shares of the healthcare conglomerate’s stock valued at $8,397,000 after buying an additional 476 shares in the last quarter. M Holdings Securities Inc. increased its stake in shares of UnitedHealth Group by 12.1% in the second quarter. M Holdings Securities Inc. now owns 5,128 shares of the healthcare conglomerate’s stock valued at $1,258,000 after buying an additional 553 shares in the last quarter. Finally, Synovus Financial Corp increased its stake in shares of UnitedHealth Group by 3.8% in the second quarter. Synovus Financial Corp now owns 53,952 shares of the healthcare conglomerate’s stock valued at $13,238,000 after buying an additional 1,985 shares in the last quarter. Hedge funds and other institutional investors own 85.44% of the company’s stock.

UnitedHealth Group stock opened at $261.01 on Friday. The stock has a market capitalization of $251.22 billion, a P/E ratio of 25.92, a PEG ratio of 1.50 and a beta of 0.78. UnitedHealth Group Inc has a 12-month low of $208.48 and a 12-month high of $272.81. The company has a current ratio of 0.69, a quick ratio of 0.75 and a debt-to-equity ratio of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.30 by $0.11. The business had revenue of $56.56 billion for the quarter, compared to analysts’ expectations of $56.34 billion. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. The firm’s quarterly revenue was up 12.4% compared to the same quarter last year. During the same quarter last year, the business earned $2.66 earnings per share. As a group, equities analysts predict that UnitedHealth Group Inc will post 12.81 earnings per share for the current fiscal year.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, August 8th. The stock was sold at an average price of $258.83, for a total transaction of $2,588,300.00. Following the transaction, the director now owns 77,172 shares in the company, valued at $19,974,428.76. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Steven H. Nelson sold 8,142 shares of the firm’s stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $265.00, for a total value of $2,157,630.00. Following the transaction, the chief executive officer now owns 22,496 shares in the company, valued at approximately $5,961,440. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 79,568 shares of company stock worth $21,128,177. Company insiders own 0.87% of the company’s stock.

UNH has been the subject of a number of research reports. Morgan Stanley raised their target price on UnitedHealth Group from $277.00 to $278.00 and gave the company a “$255.42” rating in a research note on Wednesday, July 18th. Citigroup raised their target price on UnitedHealth Group from $275.00 to $288.00 and gave the company a “$255.42” rating in a research note on Wednesday, July 18th. Royal Bank of Canada raised their target price on UnitedHealth Group from $282.00 to $284.00 and gave the company a “$255.42” rating in a research note on Wednesday, July 18th. Goldman Sachs Group restated a “buy” rating and issued a $277.00 target price on shares of UnitedHealth Group in a research note on Tuesday, July 17th. Finally, Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $287.00 price target on the stock in a report on Sunday, July 15th. One investment analyst has rated the stock with a hold rating, twenty-two have issued a buy rating and one has issued a strong buy rating to the company. UnitedHealth Group presently has an average rating of “Buy” and an average price target of $289.41.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: What does relative strength index mean?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply